PACIFIC THERAPEUTICS SIGNS DEFINATIVE AGREEMENT TO SELL FIBROSIS AND ERECTILE DYSFUNCTION THERAPEUTICS TECHNOLOGIESDefinitive Agreement • April 7th, 2017 • Tower One Wireless Corp. • Pharmaceutical preparations
VANCOUVER, BC, Canada –July 24, 2015 – Pacific Therapeutics Ltd. (CSE: PT) (OTC Markets: PCFTF) (Frankfurt: 1P3) (the “Company”) is a clinical stage specialty pharmaceutical company focused on the repurposing and reformulation of existing FDA approved drugs for large markets. The Company’s research programs have focused on diseases of excessive scarring (fibrosis) and erectile dysfunction (ED).
